BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17908668)

  • 21. Hyperthyroidism After Allogeneic Hematopoietic Stem Cell Transplantation: A Report of Four Cases.
    Sağ E; Gönç N; Alikaşifoğlu A; Kuşkonmaz B; Uçkan D; Özön A; Kandemir N
    J Clin Res Pediatr Endocrinol; 2015 Dec; 7(4):349-54. PubMed ID: 26777050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
    Sobecks RM; Le Beau MM; Anastasi J; Williams SF
    Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
    Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous stem cell transplantation in myelodysplastic syndromes.
    de Witte T; Suciu S; Brand R; Muus P; Kröger N
    Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
    Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
    Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
    Neumeister P; Strunk D; Apfelbeck U; Sill H; Linkesch W
    Lancet; 2000 Apr; 355(9212):1334-5. PubMed ID: 10776751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT.
    Hartert A; Willenbacher W; Günzelmann S; Roemer E; Basara N; Fauser AA; Kiehl MG
    Bone Marrow Transplant; 2001 Feb; 27(3):337-40. PubMed ID: 11277184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center.
    Molina A; Popplewell L; Kashyap A; Nademanee A
    Clin Transpl; 2000; ():317-42. PubMed ID: 11512326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-lymphoma effect after reduced intensity allogeneic hematopoietic stem cell transplantation from HLA-two loci mismatched father in a patient with refractory non-Hodgkin lymphoma.
    Suminoe A; Matsuzaki A; Koga Y; Hatano M; Hara T; Hara T
    Turk J Pediatr; 2009; 51(5):500-3. PubMed ID: 20112609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years.
    Lister J; Simpson JK; deMagalhaes-Silverman MM; Rybka WB; Donnenberg AD; Myers DJ; Ball ED
    Bone Marrow Transplant; 1997 May; 19(9):943-5. PubMed ID: 9156271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The promise of hematopoietic stem cell transplantation for autoimmune diseases.
    Burt RK; Traynor AE; Craig R; Marmont AM
    Bone Marrow Transplant; 2003 Apr; 31(7):521-4. PubMed ID: 12692615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.
    De Lord C; Marsh JC; Smith JG; Singer CR; Gordon-Smith EC
    Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Remission induction of refractory diffuse large B-cell lymphoma with allogeneic peripheral blood stem cell transplantation followed by interferon-alpha and donor lymphocyte infusion].
    Kawano I; Tsukada J; Toda Y; Ogawa R; Higashi T; Iwashige A; Ota T; Kubota A; Mizobe T; Morimoto H; Machida S; Tanaka Y
    Rinsho Ketsueki; 2004 Feb; 45(2):155-60. PubMed ID: 15045825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?
    Burt RK; Slavin S; Burns WH; Marmont AM
    Blood; 2002 Feb; 99(3):768-84. PubMed ID: 11806976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome.
    Nakai K; Kanda Y; Fukuhara S; Sakamaki H; Okamoto S; Kodera Y; Tanosaki R; Takahashi S; Matsushima T; Atsuta Y; Hamajima N; Kasai M; Kato S
    Leukemia; 2005 Mar; 19(3):396-401. PubMed ID: 15674354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
    Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
    Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells.
    Karthaus M; Gabrysiak T; Brabant G; Prahst A; Link H; Soudah B; Geissler RG; Diedrich H; Ganser A; Hertenstein B
    Bone Marrow Transplant; 1997 Oct; 20(8):697-9. PubMed ID: 9383236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.